Please check our newest computational study in Journal Cancers :

‘Computer-Aided Identification and Design of Ligands for Multi-Targeting Inhibition of a Molecular Acute Myeloid Leukemia Network’

https://www.mdpi.com/2072-6694/16/21/3607

Overall, by integrating network and structural pharmacology with molecular modeling, we determined two complementary strategies with the potential to annihilate the Acute myeloid leukemia (AML) network, one in the form of repurposable drug combinations and the other as a de novo synthesized triple-targeting agent.